Drug Information

Drug General Information
Drug ID
D0A9GI
Former ID
DND000031
Drug Name
ILV-095
Synonyms
PF-05212368, WAY-264095
Drug Type
Antibody
Indication Psoriasis [ICD9: 696; ICD10:L40] Phase 1 [522847]
Company
Wyeth; pfizer
Target and Pathway
Target(s) Interleukin-22 ligand Target Info [544277]
NetPath Pathway IL9 Signaling Pathway
References
Ref 522847ClinicalTrials.gov (NCT01010542) Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects. U.S. National Institutes of Health.
Ref 544277Emerging Therapies for the Treatment of Psoriasis. Dermatol Ther (Heidelb) 2012 December; 2(1): 16.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.